Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CERN

Cerner (CERN) Stock Price, News & Analysis

About Cerner Stock (NASDAQ:CERN)

Key Stats

Today's Range
$94.92
$94.92
50-Day Range
$94.92
$94.92
52-Week Range
$69.08
$95.40
Volume
1,320 shs
Average Volume
4.00 million shs
Market Capitalization
$27.92 billion
P/E Ratio
47.70
Dividend Yield
1.14%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.

Cerner Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 67th Percentile

Cerner scored higher than 67% of companies evaluated by MarketBeat, and ranked 387th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Cerner are expected to grow by 10.19% in the coming year, from $3.14 to $3.46 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cerner is 47.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.23.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cerner is 47.70, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 146.78.

  • Price to Earnings Growth Ratio

    Cerner has a PEG Ratio of 2.37. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Cerner has a P/B Ratio of 7.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CERN.
  • Dividend Yield

    Cerner pays a meaningful dividend of 1.14%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Cerner does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Cerner is 54.27%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Cerner will have a dividend payout ratio of 31.21% next year. This indicates that Cerner will be able to sustain or increase its dividend.

  • Read more about Cerner's dividend.
  • Short Interest

    There is no current short interest data available for CERN.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Cerner this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for CERN on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cerner insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.12% of the stock of Cerner is held by insiders.

  • Percentage Held by Institutions

    82.23% of the stock of Cerner is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cerner's insider trading history.
Receive CERN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerner and its competitors with MarketBeat's FREE daily newsletter.

CERN Stock News Headlines

Have you heard of this 5-Day Challenge yet?
You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...
See More Headlines

CERN Stock Analysis - Frequently Asked Questions

Cerner Co. (NASDAQ:CERN) issued its quarterly earnings data on Thursday, October, 28th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.82 by $0.04. The business's revenue was up 7.2% on a year-over-year basis.
Read the conference call transcript
.

Cerner shares reverse split before market open on Saturday, January 1st 2000. The 0.75-1.5 reverse split was announced on Saturday, January 1st 2000. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 1st 2013. An investor that had 100 shares of stock prior to the reverse split would have 50 shares after the split.

The following companies are subsidiaries of Cerner: Kantar Health, AbleVets, Siemens Healthineers, LABOTIX Automation, PureWellness Inc, Anasazi Software Inc., Clairvia Inc, and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cerner investors own include NVIDIA (NVDA), Walt Disney (DIS), QUALCOMM (QCOM), Cisco Systems (CSCO), Gilead Sciences (GILD), Intel (INTC) and Netflix (NFLX).

Company Calendar

Last Earnings
10/28/2021
Today
9/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer Integrated Systems Design
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:CERN
CUSIP
15678210
Employees
25,150
Year Founded
1979

Profitability

Net Income
$555.60 million
Pretax Margin
12.61%

Debt

Sales & Book Value

Annual Sales
$5.76 billion
Cash Flow
$5.37 per share
Book Value
$12.56 per share

Miscellaneous

Free Float
293,745,000
Market Cap
$27.92 billion
Optionable
Optionable
Beta
0.77

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Should I Buy Cerner Stock? CERN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 10, 2024. Please send any questions or comments about these Cerner pros and cons to contact@marketbeat.com.

Cerner
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Cerner Co.:

  • Cerner Co. has shown consistent growth in revenue and market share in the health care technology sector, indicating a strong position in the industry.
  • The company's innovative Cerner Millennium architecture provides a comprehensive suite of health care information technology solutions, attracting a wide range of clients from integrated delivery networks to pharmaceutical manufacturers.
  • Recent developments in Cerner Co.'s tech-enabled services, such as real-world evidence and clinical process optimization, showcase the company's commitment to staying at the forefront of health care technology advancements.
  • Cerner Co.'s stock price has been performing well, showing resilience and potential for further growth in the market.
  • The company's expansion into international markets presents opportunities for increased revenue streams and global recognition.

Cerner
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Cerner Co. for these reasons:

  • Cerner Co. faces intense competition in the health care technology sector, which could impact its market share and profitability.
  • The company's reliance on tech-enabled services and software solutions makes it vulnerable to rapid technological changes and cybersecurity threats.
  • Regulatory changes in the health care industry could affect Cerner Co.'s operations and revenue streams, leading to uncertainties in future financial performance.
  • Fluctuations in the global economy and health care spending trends may impact the demand for Cerner Co.'s products and services.
  • Investors should carefully monitor the company's financial reports and market positioning to make informed decisions due to the dynamic nature of the health care technology sector.

This page (NASDAQ:CERN) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners